Biocept appoints financial executive quyen dao-haddock to its board of directors

San diego--( business wire )--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, announces the appointment of quyen dao-haddock to its board of directors, effective immediately, increasing board membership to eight. ms. dao-haddock is a certified public accountant (cpa) with more than 20 years of financial and accounting experience. she will serve on biocept's audit committee.
BIOC Ratings Summary
BIOC Quant Ranking